Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

is concerned about the lack of awareness around Fragile X syndrome and about how common it is. “There is a surprising lack of ...

Scientists have created a new therapeutic approach for testing fragile X syndrome, which is the most common genetic cause of ...

a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism ...

Exclusive: A world-first Australian study could pave the way for all couples to have free genetic screening before starting a ...

Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and a leading monogenic cause of autism, yet effective treatments remain elusive. Previous work showed that ...

Boosting NMDA receptor signaling corrected excess protein synthesis in Fragile X model mice. Experimental drug Glyx-13 restored synaptic plasticity and reduced seizures in mice. Findings open the door ...

A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing targeted treatment for FXS.

a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism ...

Fragile X syndrome is the most common genetically-caused autism spectrum disorder. It causes a range of developmental issues, ...